Item(by='refurb', descendants=None, kids=None, score=None, time=1611700732, title=None, item_type='comment', url=None, parent=25919640, text='The hepatitis C cures was massively profitable.  Gilead paid $11B for Pharmasset’s portfolio and everyone said they were dumb.<p>They then had sales of $10.4B in the first year on the market.  That’s one year and one drug (they’ve developed newer drugs and launched those too).')